NOLC1 and neoplasm: Furthermore, the identification of this ceRNA mechanism not only offers novel insights into the progression of CC but also underscores circ-NOLC1 as a potential prognostic biomarker and therapeutic target for restoring PALM-dependent tumor-suppressive functions in CC.